Haematology (incl blood transfusion)

Showing results 41 - 50 of 100

Sorted by most recent

TitleAuthorDate

Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial

Masahiro Takeyama, Naoki Ozu, Shu Kasama, Masato Kasahara, Masanori Matsumoto, Midori Shima, Keiji Nogami

10 July 2023

Low-dose intravenous immunoglobulin for children with newly diagnosed immune thrombocytopenia: protocol of a systematic review and meta-analysis

Xiangge Ren, Miaomiao Zhang, Xiaohan Zhang, Peidong Zhao, Wensheng Zhai

29 June 2023

DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A

Anouk Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer

26 June 2023

ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission

David I Marks, Anna Castleton, Eduardo Olavarria, Maria Gilleece, Adele Fielding, George Mikhaeel, Matthew Beasley, Patricia Diez, Aimee Jackson, Andrea Hodgkinson, Mohamed Elhanied, Ronjon Chakraverty

1 June 2023

Effect of cognitive–behavioural therapy on resilience and relapse in adult patients with substance use disorder: a systematic review protocol

Ibraheem Mhaidat, Mohammad Reza Taherian, Seyed Saeed Hashemi Nazari, Alireza Mosavi-Jarrahi, Haniye Yeganeh, Nabeel Al-Yateem, Amina M Al Marzouqi, Syed Azizur Rahman

12 May 2023

Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study)

Aurore Dougé, Aurélie Ravinet, Alexandrine Corriger, Aurélie Cabrespine, Mathieu Wasiak, Bruno Pereira, Harry Sokol, Stéphanie Nguyen, Jacques-Olivier Bay

2 May 2023

Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I–II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21)

Hirotoshi Sakaguchi, Katsustugu Umeda, Itaru Kato, Kimiyoshi Sakaguchi, Hidefumi Hiramatsu, Hiroyuki Ishida, Hiromasa Yabe, Hiroaki Goto, Yuta Kawahara, Yuka Iijima Yamashita, Masashi Sanada, Takao Deguchi, Yoshiyuki Takahashi, Akiko Saito, Hisashi NomaSee the full list of authors

17 April 2023

Efficacy and safety of novel oral anticoagulants for the treatment of cancer-associated venous thromboembolism: protocol for an umbrella review of systematic reviews and meta-analyses

Yunqing Xia, Liang Tang, Yu Hu

6 April 2023

The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design

Rachael F Grace, Eduard J van Beers, Joan-Lluis Vives Corrons, Bertil Glader, Andreas Glenthøj, Hitoshi Kanno, Kevin H M Kuo, Carl Lander, D Mark Layton, Dagmar Pospíŝilová, Vip Viprakasit, Junlong Li, Yan Yan, Audra N Boscoe, Chris BowdenSee the full list of authors

23 March 2023

Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia

Ali T Taher, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher Pelligra, Alan L Shields, Jeevan K Shetty, Dimana Miteva, Luciana Moro Bueno, Maria Domenica Cappellini

22 March 2023

Prev 1 2 3 456 7 8 9 10 Next